Previous Close | 0.6000 |
Open | 0.6000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.6000 - 0.6000 |
52 Week Range | 0.4850 - 1.8500 |
Volume | |
Avg. Volume | 528 |
Market Cap | 2.427M |
Beta (5Y Monthly) | 3.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets. Today IDenta Corp reported its 2022 first quarter financial statement and expands activity in the U.S. and European markets.
IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets. The company is now promoting its consumer brand Touch&Know kits for Drug and Fentanyl Detection on all American Airlines domestic flights. The products will be available through the airline's entertainment service on approximately 80,000 flights during the month of May. The lau
IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets. The company won a tender and was selected to supply drug test kits to the security forces of Italy. This tender was awarded after passing extensive testing, demonstrating that IDenta's products were superior to the rest of the competitors.